Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H29N |
| Molecular Weight | 295.4617 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)N(CCC(C1=CC=CC=C1)C2=CC=CC=C2)C(C)C
InChI
InChIKey=YBJKOPHEJOMRMN-UHFFFAOYSA-N
InChI=1S/C21H29N/c1-17(2)22(18(3)4)16-15-21(19-11-7-5-8-12-19)20-13-9-6-10-14-20/h5-14,17-18,21H,15-16H2,1-4H3
| Molecular Formula | C21H29N |
| Molecular Weight | 295.4617 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Diisopromine, a spasmolytic and a choleretic, in combination with sorbitol was marketed under the brand name Agofell. Agofell is prescribed for the biliary stasis and biliary insufficiency, hypotonia of the gall bladder, spasm of the biliary duct and of the sphincter of Oddi, cholecystitis, cholelithiasis, post cholecystotomy syndrome.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:17:37 UTC 2023
by
admin
on
Fri Dec 15 16:17:37 UTC 2023
|
| Record UNII |
2825S6AW9U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29696
Created by
admin on Fri Dec 15 16:17:37 UTC 2023 , Edited by admin on Fri Dec 15 16:17:37 UTC 2023
|
||
|
WHO-VATC |
QA03AX02
Created by
admin on Fri Dec 15 16:17:37 UTC 2023 , Edited by admin on Fri Dec 15 16:17:37 UTC 2023
|
||
|
WHO-ATC |
A03AX02
Created by
admin on Fri Dec 15 16:17:37 UTC 2023 , Edited by admin on Fri Dec 15 16:17:37 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C80978
Created by
admin on Fri Dec 15 16:17:37 UTC 2023 , Edited by admin on Fri Dec 15 16:17:37 UTC 2023
|
PRIMARY | |||
|
SUB07143MIG
Created by
admin on Fri Dec 15 16:17:37 UTC 2023 , Edited by admin on Fri Dec 15 16:17:37 UTC 2023
|
PRIMARY | |||
|
m694
Created by
admin on Fri Dec 15 16:17:37 UTC 2023 , Edited by admin on Fri Dec 15 16:17:37 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000082608
Created by
admin on Fri Dec 15 16:17:37 UTC 2023 , Edited by admin on Fri Dec 15 16:17:37 UTC 2023
|
PRIMARY | |||
|
227-752-4
Created by
admin on Fri Dec 15 16:17:37 UTC 2023 , Edited by admin on Fri Dec 15 16:17:37 UTC 2023
|
PRIMARY | |||
|
236206
Created by
admin on Fri Dec 15 16:17:37 UTC 2023 , Edited by admin on Fri Dec 15 16:17:37 UTC 2023
|
PRIMARY | RxNorm | ||
|
Diisopromine
Created by
admin on Fri Dec 15 16:17:37 UTC 2023 , Edited by admin on Fri Dec 15 16:17:37 UTC 2023
|
PRIMARY | |||
|
DTXSID60208343
Created by
admin on Fri Dec 15 16:17:37 UTC 2023 , Edited by admin on Fri Dec 15 16:17:37 UTC 2023
|
PRIMARY | |||
|
22262
Created by
admin on Fri Dec 15 16:17:37 UTC 2023 , Edited by admin on Fri Dec 15 16:17:37 UTC 2023
|
PRIMARY | |||
|
989
Created by
admin on Fri Dec 15 16:17:37 UTC 2023 , Edited by admin on Fri Dec 15 16:17:37 UTC 2023
|
PRIMARY | |||
|
DB13476
Created by
admin on Fri Dec 15 16:17:37 UTC 2023 , Edited by admin on Fri Dec 15 16:17:37 UTC 2023
|
PRIMARY | |||
|
CHEMBL2110849
Created by
admin on Fri Dec 15 16:17:37 UTC 2023 , Edited by admin on Fri Dec 15 16:17:37 UTC 2023
|
PRIMARY | |||
|
892
Created by
admin on Fri Dec 15 16:17:37 UTC 2023 , Edited by admin on Fri Dec 15 16:17:37 UTC 2023
|
PRIMARY | |||
|
2825S6AW9U
Created by
admin on Fri Dec 15 16:17:37 UTC 2023 , Edited by admin on Fri Dec 15 16:17:37 UTC 2023
|
PRIMARY | |||
|
5966-41-6
Created by
admin on Fri Dec 15 16:17:37 UTC 2023 , Edited by admin on Fri Dec 15 16:17:37 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
